Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,242 | 8,317 | 2,290 | 58,053 | 39,911 |
| Depreciation Amortization | 6,126 | 4,146 | 2,096 | 6,722 | 4,683 |
| Income taxes - deferred | -6,494 | -2,343 | -585 | -4,914 | -2,572 |
| Accounts receivable | 13,711 | 7,873 | 26,609 | -23,770 | -6,935 |
| Other Working Capital | 3,188 | -10,641 | 4,901 | 34,426 | 29,566 |
| Other Operating Activity | 6,329 | 903 | -23,136 | 31,761 | 10,386 |
| Operating Cash Flow | $34,102 | $8,255 | $12,175 | $102,278 | $75,039 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 75,971 | 35,396 | 16,607 | 36,643 | 26,321 |
| PPE Investments | -7,349 | -4,501 | -2,623 | -13,842 | -10,743 |
| Purchase Of Investment | -85,482 | -42,232 | -22,574 | -138,470 | -84,036 |
| Sale Of Investment | 7,146 | 4,324 | 2,108 | 25,492 | 11,595 |
| Investing Cash Flow | $-9,714 | $-7,013 | $-6,482 | $-90,177 | $-56,863 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,051 | 3,699 | 1,310 | 12,171 | 8,841 |
| Common Stock Repurchased | -16,100 | -16,100 | -13,351 | -16,459 | 0 |
| Other Financing Activity | 675 | 934 | 653 | 13,596 | 8,857 |
| Financing Cash Flow | $-10,374 | $-11,467 | $-11,388 | $9,308 | $17,698 |
| Beginning Cash Position | 79,515 | 79,515 | 79,515 | 58,106 | 58,106 |
| End Cash Position | 93,529 | 69,290 | 73,820 | 79,515 | 93,980 |
| Net Cash Flow | $14,014 | $-10,225 | $-5,695 | $21,409 | $35,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | 34,102 | 8,255 | 12,175 | 102,278 | 75,039 |
| Capital Expenditure | -7,349 | -4,501 | -2,623 | -13,842 | -10,743 |
| Free Cash Flow | 26,753 | 3,754 | 9,552 | 88,436 | 64,296 |